Pulmonx Corp (FRA:4NI)
€ 1.76 +0.080 (+4.79%) Market Cap: 85.11 Mil Enterprise Value: 85.43 Mil PE Ratio: 0 PB Ratio: 2.51 GF Score: 62/100

Q4 2025 Pulmonx Corp Earnings Call Transcript

Mar 4, 2026 / 09:30 PM GMT
Release Date Price: €1.25 (+0.81%)

Key Points

Positve
  • Pulmonx Corp (LUNG) has executed a cost restructuring initiative, reducing ongoing operating expenses by over 10%, which strengthens their financial outlook.
  • The company closed on a $60 million credit facility with a 5-year interest-only structure, extending debt maturity to 2031 and providing additional financial flexibility.
  • Pulmonx Corp (LUNG) has filled the majority of open US sales positions, which is expected to drive sales growth in the latter half of the year.
  • The company is focusing on high-impact mandates and streamlining priorities to enhance sales team efficiency and effectiveness.
  • Enrollment momentum in the Aeroseal program is accelerating, with expectations to complete the trial by 2027, potentially expanding the market by 20% globally.
Negative
  • Pulmonx Corp (LUNG) experienced a 5% decrease in worldwide revenue in Q4 2025 compared to the same period last year.
  • US revenue in Q4 2025 decreased by 11% year-over-year, indicating challenges in the domestic market.
  • The company faced significant turnover in the US sales organization during 2025, disrupting customer continuity and account management.
  • Sales incentive structures in 2025 were suboptimal, leading to difficulties in effectively motivating the sales team.
  • International revenue growth was offset by a lack of sales to the distributor in China, with expectations for minimal sales in the first half of 2026.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

LUNG.OQ - Pulmonx Corp
Q4 2025 Pulmonx Corp Earnings Call
Mar 04, 2026 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and thank you for standing by. Welcome to the Pomonics 4th quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, we'll open up for questions. To ask a question during the session, you will need to press 11 on your telephone. You'll then hear an automated message advising your hand is raised to withdraw your question, please press 11 again. Please be advised that today's call is being recorded. I would now like to hand it over to your speaker today, Lane Morgan. Investor relations, please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-----------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot